GO:0048013 ephrin receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048013 (ephrin receptor signaling pathway) describes the molecular cascade triggered when an ephrin ligand binds an Eph receptor, culminating in regulation of downstream cellular processes such as transcription.
• Eph receptors form the largest family of receptor tyrosine kinases, and their signaling is unusual because both the receptor and the ephrin ligand can transmit signals (bidirectional signaling).
• Eph/ephrin signaling controls cell repulsion, adhesion, migration, boundary formation, and tissue patterning during development and in adult homeostasis.
• Dysregulated ephrin receptor signaling is implicated in cancer progression, vascular leak in sepsis, and reproductive pathologies, making it a therapeutic target.
• The pathway is regulated by receptor clustering, homotypic receptor-receptor interactions, and membrane organization, which tune signal strength and specificity.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect causal roles of Eph/ephrin genes in disease.
Description
The ephrin receptor signaling pathway (GO:0048013) is a biological process defined as the series of molecular signals initiated by ephrin binding to its receptor and ending with regulation of a downstream cellular process, for example transcription. Eph receptors constitute the largest family of receptor tyrosine kinases, and their ligands, the ephrins, are membrane-anchored proteins, so signaling typically requires direct cell-cell contact. This pathway is highly conserved and controls fundamental processes including cell repulsion, adhesion, migration, and boundary formation during development and in adult tissues. Because Eph/ephrin signaling coordinates cell positioning and tissue architecture, its dysregulation contributes to cancer, vascular dysfunction, and reproductive disorders. Understanding the precise molecular steps and regulatory layers of this pathway is therefore essential for both developmental biology and translational medicine.
ephrin receptor signaling pathway At A Glance
| GO ID | GO:0048013 |
|---|---|
| GO term | ephrin receptor signaling pathway |
| Ontology | biological_process |
| Synonym | Eph receptor signaling pathway; Eph receptor signalling pathway |
| Definition | The series of molecular signals initiated by ephrin binding to its receptor, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| Major function | Cell-cell communication controlling repulsion, adhesion, migration, boundary formation, and transcription |
| Key receptors | EphA and EphB receptor tyrosine kinases |
| Key ligands | Ephrin-A (GPI-anchored) and ephrin-B (transmembrane) proteins |
| Signaling mode | Bidirectional signaling; both receptor and ligand can transmit signals |
What Is GO:0048013?
In our own words, GO:0048013 (ephrin receptor signaling pathway) is the entire sequence of molecular events that begins when an ephrin ligand engages an Eph receptor on a neighboring cell and ends with changes in a downstream cellular process, such as altered gene transcription. The term covers receptor activation, intracellular signal transduction, and the resulting cellular response, and it is synonymous with Eph receptor signaling pathway.
Why Is ephrin receptor signaling pathway Important in Cell Biology?
Ephrin receptor signaling is critically important because it governs how cells communicate with their neighbors to organize tissues, and its dysfunction is linked to major human diseases including cancer, sepsis-associated vascular leak, and reproductive disorders. The pathway is also a paradigm for understanding how receptor clustering and membrane organization control signal output, which has broad implications for kinase biology and drug development.
• Controls cell repulsion and adhesion, essential for tissue boundary formation and migration.
• Regulates neurogenesis and neural circuit formation in the developing brain.
• Modulates vascular permeability; inhibition reduces endothelial dysfunction in sepsis models.
• Implicated in cancer progression, including tumor growth, metastasis, and angiogenesis.
• Plays roles in female reproductive physiology and pathology.
• Exhibits bidirectional signaling, making it a unique model for cell-cell communication.
• Receptor clustering and homotypic interactions fine-tune signaling strength.
• Provides therapeutic targets for oncology, inflammation, and regenerative medicine.
What Happens During ephrin receptor signaling pathway?
Ligand binding and receptor activation
In simple terms: An ephrin on one cell binds an Eph receptor on another cell, switching the receptor on.
The pathway begins when a membrane-bound ephrin ligand on one cell engages the extracellular domain of an Eph receptor on an adjacent cell. This interaction induces receptor dimerization and activation of its intracellular tyrosine kinase domain, leading to autophosphorylation and initiation of downstream signals.
Bidirectional signaling
In simple terms: Both the receptor and the ligand can send signals into their own cells.
Unlike many receptor-ligand systems, Eph/ephrin binding triggers signaling in both directions: forward signaling through the Eph receptor and reverse signaling through the ephrin ligand. This bidirectional communication allows reciprocal regulation of the two interacting cells.
Receptor clustering and signal amplification
In simple terms: Receptors group together on the membrane to strengthen the signal.
Eph receptors assemble into clusters and higher-order signaling complexes in the plasma membrane. Homotypic receptor-receptor interactions and membrane organization modulate the strength and duration of signaling, ensuring context-appropriate responses.
Downstream cytoskeletal and transcriptional responses
In simple terms: The signal changes the cell's skeleton and gene expression.
Activated Eph receptors recruit adaptor proteins and regulate Rho-family GTPases, leading to cytoskeletal rearrangements that control cell repulsion, adhesion, and migration. Signals also propagate to the nucleus to regulate transcription, thereby influencing cell fate and behavior.
Termination and feedback
In simple terms: The signal is switched off to avoid overactivity.
Signaling is terminated by receptor internalization, degradation, and negative feedback loops. Proper regulation is essential because persistent Eph/ephrin activity can disrupt tissue architecture and contribute to disease.
Key Genes Involved in GO:0048013 ephrin receptor signaling pathway
The following genes and proteins are central components of the ephrin receptor signaling pathway (GO:0048013) and are frequently studied in functional genomics and disease research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EPHA2 | Ephrin type-A receptor 2; mediates cell repulsion and adhesion | Overexpressed in many cancers; therapeutic target |
| EPHA4 | Ephrin type-A receptor 4; regulates axon guidance and neurogenesis | Studied in neural development and regeneration |
| EPHB2 | Ephrin type-B receptor 2; controls intestinal stem cell maintenance | Linked to stem cell biology and cancer |
| EPHB4 | Ephrin type-B receptor 4; regulates vascular development | Implicated in angiogenesis and vascular leak |
| EFNA1 | Ephrin-A1 ligand; activates EphA receptors | Involved in tumor angiogenesis and inflammation |
| EFNA5 | Ephrin-A5 ligand; roles in neural patterning | Studied in neurogenesis and cell migration |
| EFNB1 | Ephrin-B1 ligand; bidirectional signaling | Associated with craniofacial and skeletal development |
| EFNB2 | Ephrin-B2 ligand; vascular and lymphatic patterning | Target in vascular biology and sepsis |
| RHO GTPases (e.g., RHOA, RAC1) | Downstream effectors of Eph signaling | Key for cytoskeletal remodeling and migration |
| SRC family kinases | Modulate Eph receptor phosphorylation | Studied in signal transduction |
| GRB2 | Adaptor protein linking Eph receptors to downstream pathways | Involved in signal propagation |
| PI3K/AKT pathway components | Survival and proliferation signals downstream of Eph | Cancer research |
| MAPK/ERK pathway components | Transcription regulation downstream of Eph | Cell fate and proliferation studies |
| MMPs (e.g., MMP2, MMP9) | Extracellular matrix remodeling upon Eph activation | Invasion and metastasis research |
| VEGFA | Angiogenesis factor interacting with Eph signaling | Vascular biology and cancer |
| CDH1 (E-cadherin) | Adhesion molecule modulated by Eph signaling | Epithelial-mesenchymal transition studies |
| NOTCH pathway genes | Crosstalk with Eph in stem cell maintenance | Intestinal stem cell research |
How Is ephrin receptor signaling pathway Regulated?
Ephrin receptor signaling is tightly regulated at multiple levels. Receptor clustering and homotypic receptor-receptor interactions in the plasma membrane modulate signal strength and specificity. Bidirectional signaling ensures that both the receptor-expressing and ligand-expressing cells can adjust their responses. Negative feedback mechanisms, including receptor internalization and degradation, prevent excessive signaling. Crosstalk with other pathways, such as muscarinic receptor M3 signaling in intestinal stem cells, further tunes EphB/ephrin-B activity. In disease contexts, dysregulated Eph signaling can be targeted pharmacologically, as shown by reduced vascular leak in sepsis models upon Eph/ephrin inhibition.
ephrin receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EPHA2 | Cancer (overexpression, metastasis) | Knockout and overexpression in cancer cell lines |
| EPHB4 | Sepsis-associated vascular leak | Endothelial-specific knockout mouse |
| EFNB2 | Vascular and lymphatic disorders | Knock-in and knockout models |
| EPHB2 | Intestinal stem cell maintenance and cancer | Conditional knockout in intestinal epithelium |
| EPHA4 | Neurodevelopmental disorders | Knockout and point-mutation models in neurons |
Cancer
EphA2 and other Eph receptors are frequently overexpressed in tumors and promote proliferation, migration, invasion, and angiogenesis. Targeting EphA2 signaling is an active area of cancer therapeutic development. Eph/ephrin signaling also influences metastasis by modulating cell adhesion and extracellular matrix remodeling.
Sepsis and vascular dysfunction
Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mouse models of sepsis, highlighting the pathway as a potential therapeutic target for inflammatory vascular injury.
Reproductive disorders
Ephrin and Eph receptor signaling play important roles in female reproductive physiology, including ovarian function and embryo implantation, and their dysregulation is associated with reproductive pathologies.
Neurological and developmental disorders
Eph/ephrin signaling is critical for neurogenesis and neural circuit formation; disruptions can affect brain development and may contribute to neurological conditions.
From ephrin receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of EPHA2 affect tumor growth? | CRISPR knockout in cancer cell lines and xenografts |
| Does a specific point mutation in EPHB4 alter kinase activity? | CRISPR point-mutation knock-in |
| How does ephrin-B2 reverse signaling affect vascular permeability? | Endothelial-specific knockout or knock-in mouse |
| Can tagged Eph receptors reveal real-time clustering? | CRISPR knock-in of fluorescent tags |
| Does overexpression of EFNA1 drive angiogenesis? | CRISPR overexpression in endothelial cells |
| What is the role of EphB2 in intestinal stem cells? | Conditional knockout and organoid models |
How to Study the ephrin receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality and pathway dependencies | Cancer and stem cell research |
| Phosphoproteomics | Receptor phosphorylation and signaling nodes | Mechanistic studies of Eph activation |
| Live-cell imaging | Receptor clustering and dynamics | Cell-cell communication studies |
| RNA-seq | Transcriptional changes | Downstream gene expression analysis |
| Co-immunoprecipitation | Protein-protein interactions | Identifying Eph signaling complexes |
| Proximity ligation assay | In situ protein interactions | Visualizing receptor complexes |
| Organoid culture | Tissue-level function | Intestinal stem cell studies |
| Animal models (KO/knock-in) | In vivo pathway function | Disease modeling |
CRISPR knockout screens
Genome-wide CRISPR knockout screens can identify Eph/ephrin pathway components required for cell migration, proliferation, or drug resistance. Such screens have been used to uncover dependencies in cancer cells.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics measures changes in Eph receptor autophosphorylation and downstream signaling upon ligand stimulation or genetic perturbation.
Live-cell imaging
Fluorescent tagging of Eph receptors and ephrins enables real-time visualization of receptor clustering, internalization, and cell-cell contact dynamics.
Transcriptomics (RNA-seq)
RNA sequencing reveals transcriptional changes downstream of Eph activation, helping to map the pathway's impact on gene expression programs.
How CRISPR Can Be Used to Study GO:0048013 ephrin receptor signaling pathway
Knockout
CRISPR knockout of Eph receptor or ephrin genes in cell lines and animal models allows researchers to assess loss-of-function phenotypes, such as altered migration, proliferation, or vascular permeability.
Point Mutation
Introducing specific point mutations in Eph receptor kinase domains or ephrin binding interfaces via CRISPR enables structure-function studies and modeling of disease-associated variants.
Knock-in
CRISPR knock-in of fluorescent tags, epitope tags, or reporter cassettes into endogenous Eph/ephrin loci facilitates real-time imaging and biochemical analysis of the pathway.
Overexpression
CRISPR-mediated overexpression of ephrins or Eph receptors can model gain-of-function states observed in cancer and other diseases, enabling studies of oncogenic signaling.
How EDITGENE Supports ephrin receptor signaling pathway Research
Researchers studying ephrin receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for ephrin receptor signaling pathway research.
Frequently Asked Questions About ephrin receptor signaling pathway
What is the ephrin receptor signaling pathway?
It is the biological process (GO:0048013) initiated by ephrin binding to Eph receptors, leading to regulation of downstream cellular processes such as transcription.
What genes are involved in ephrin receptor signaling pathway?
Key genes include EPHA2, EPHA4, EPHB2, EPHB4, EFNA1, EFNA5, EFNB1, and EFNB2, as well as downstream effectors like Rho GTPases.
What is the function of GO:0048013?
GO:0048013 describes the molecular signals that control cell repulsion, adhesion, migration, and transcription in response to ephrin binding.
How is ephrin receptor signaling regulated?
It is regulated by receptor clustering, homotypic interactions, bidirectional signaling, and negative feedback via internalization.
What diseases are associated with ephrin receptor signaling?
Cancer, sepsis-associated vascular leak, reproductive disorders, and neurological conditions have been linked to this pathway.
What is bidirectional signaling in Eph/ephrin pathway?
It means that both the Eph receptor and the ephrin ligand can transmit signals into their respective cells upon binding.
How can CRISPR be used to study ephrin receptor signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise functional dissection of Eph/ephrin genes in vitro and in vivo.
What are the major Eph receptors?
EphA and EphB receptor tyrosine kinases form the largest family of receptor tyrosine kinases, with EPHA2, EPHA4, EPHB2, and EPHB4 being well-studied members.
What is the role of EphB2 in intestinal stem cells?
EphB/ephrin-B signaling, influenced by muscarinic receptor M3, contributes to intestinal stem cell maintenance.
How does EphA2 contribute to cancer?
EphA2 is often overexpressed in tumors and promotes proliferation, migration, invasion, and angiogenesis, making it a therapeutic target.
Conclusion
The ephrin receptor signaling pathway (GO:0048013) is a fundamental cell-cell communication system that controls tissue organization, migration, and gene expression. Its dysregulation is implicated in cancer, vascular disease, and reproductive pathologies, making it a high-priority research area. Advances in CRISPR-based models and multi-omics approaches are accelerating the discovery of precise therapeutic targets within this pathway.
References
- 1. Khan N et al.. 2024. Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsis.. Sci Transl Med 16(744):eadg5768 PMID: 38657024
- 2. Arvanitis D et al.. 2008. Eph/ephrin signaling: networks.. Genes Dev 22(4):416-29 PMID: 18281458
- 3. Adu-Gyamfi EA et al.. 2021. Ephrin and Eph receptor signaling in female reproductive physiology and pathology†.. Biol Reprod 104(1):71-82 PMID: 32940657
- 4. Pasquale EB. 2024. Eph receptor signaling complexes in the plasma membrane.. Trends Biochem Sci 49(12):1079-1096 PMID: 39537538
- 5. Nehal M et al.. 2024. Exploring the potential of EphA2 receptor signaling pathway: a comprehensive review in cancer treatment.. Mol Biol Rep 51(1):337 PMID: 38393520
- 6. Laussu J et al.. 2014. Beyond boundaries--Eph:ephrin signaling in neurogenesis.. Cell Adh Migr 8(4):349-59 PMID: 25482631
- 7. Takahashi T et al.. 2021. Muscarinic receptor M3 contributes to intestinal stem cell maintenance via EphB/ephrin-B signaling.. Life Sci Alliance 4(9) PMID: 34244422
- 8. Nikolov DB et al.. 2014. Homotypic receptor-receptor interactions regulating Eph signaling.. Cell Adh Migr 8(4):360-5 PMID: 25530219
